BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1030820)

  • 1. Pharmacokinetic interpretation of erythromycin and tylosin activity in serum after intravenous administration of a single dose to cows.
    Baggot JD; Gingerich DA
    Res Vet Sci; 1976 Nov; 21(3):318-23. PubMed ID: 1030820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pharmacokinetic analysis of tylosin in the normal dog.
    Weisel MK; Powers JD; Powers TE; Baggot JD
    Am J Vet Res; 1977 Feb; 38(2):273-5. PubMed ID: 842925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of tylosin in broiler chickens.
    Kowalski C; Roliński Z; Zań R; Wawron W
    Pol J Vet Sci; 2002; 5(3):127-30. PubMed ID: 12448074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and tissue residue profiles of erythromycin in broiler chickens after different routes of administration.
    Goudah A; Abo El Sooud K; Abd El-Aty AM
    Dtsch Tierarztl Wochenschr; 2004 Apr; 111(4):162-5. PubMed ID: 15171602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of microbiologic and high-performance liquid chromatography assays to determine plasma concentrations, pharmacokinetics, and bioavailability of erythromycin base in plasma of foals after intravenous or intragastric administration.
    Lakritz J; Wilson WD; Mihalyi JE
    Am J Vet Res; 1999 Apr; 60(4):414-9. PubMed ID: 10211682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and mammary residual depletion of erythromycin in healthy lactating ewes.
    Goudah A; Sher Shah S; Shin HC; Shim JH; Abd El-Aty AM
    J Vet Med A Physiol Pathol Clin Med; 2007 Dec; 54(10):607-11. PubMed ID: 18045347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacokinetic profile of ochratoxin A in the rat after oral and intravenous administration.
    Galtier P; Charpenteau JL; Alvinerie M; Labouche C
    Drug Metab Dispos; 1979; 7(6):429-34. PubMed ID: 43233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of erythromycin in nonlactating and lactating goats after intravenous and intramuscular administration.
    Ambros L; Montoya L; Kreil V; Waxman S; Albarellos G; Rebuelto M; Hallu R; San Andres MI
    J Vet Pharmacol Ther; 2007 Feb; 30(1):80-5. PubMed ID: 17217406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disposition kinetics of ketamine in the domestic cat.
    Baggot JD; Blake JW
    Arch Int Pharmacodyn Ther; 1976 Mar; 220(1):115-24. PubMed ID: 952572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disposition of tylosin in goats.
    Atef M; Youssef SA; Atta AH; el-Maaz AA
    Dtsch Tierarztl Wochenschr; 1991 Dec; 98(12):451-3. PubMed ID: 1790764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the relationship between serum and milk residue disposition of ceftriaxone in lactating ewes.
    Goudah A; Shin HC; Shim JH; Abd El-Aty AM
    J Vet Pharmacol Ther; 2006 Aug; 29(4):307-12. PubMed ID: 16846468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition kinetics of tylosin administered intravenously and intramuscularly in desert sheep and Nubian goats.
    Taha AA; Elsheikh HA; Khalafalla AE; Osman IA; Abdullah AS
    Vet J; 1999 Nov; 158(3):210-5. PubMed ID: 10558841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromatographic methods for determination of macrolide antibiotic residues in tissues and milk of food-producing animals.
    Moats WA
    J Assoc Off Anal Chem; 1985; 68(5):980-4. PubMed ID: 4055648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbiological screening test validation for detection of tylosin excretion in milk of cows with low and high somatic cell counts.
    Litterio NJ; Calvinho LF; Flores MM; Tarabla HD; Boggio JC
    J Vet Med A Physiol Pathol Clin Med; 2007 Feb; 54(1):30-5. PubMed ID: 17359452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacokinetics of cefamandole in rabbits].
    Klimova VS; Bobrov VI; Nazarova OI; Skala LZ; Iakovlev VP
    Antibiotiki; 1982 Dec; 27(12):34-8. PubMed ID: 7165292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of erythromycin treatment delay on therapeutic outcome of experimental acute otitis media caused by Streptococcus pneumoniae.
    Martínez-Marín C; Huelves L; del Prado G; García-Cía JI; Cenjor C; Ponte C; Granizo JJ; Soriano F
    J Antimicrob Chemother; 2005 Oct; 56(4):783-6. PubMed ID: 16144869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of liquid chromatographic and bioassay procedures for determining depletion of intramuscularly injected tylosin.
    Moats WA; Harris EW; Steele NC
    J Assoc Off Anal Chem; 1985; 68(3):413-6. PubMed ID: 4019360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of erythromycin after the administration of intravenous and various oral dosage forms to dogs.
    Albarellos GA; Kreil VE; Ambros LA; Waxman S; Montoya L; Tarragona L; Quaine PC; Hallu RE; Rebuelto M
    J Vet Pharmacol Ther; 2008 Dec; 31(6):496-500. PubMed ID: 19000270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and tissue concentrations of tylosin in selected avian species.
    Locke D; Bush M; Carpenter JW
    Am J Vet Res; 1982 Oct; 43(10):1807-10. PubMed ID: 7149381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic disposition in experimental pneumonic pasteurellosis: gentamicin and tylosin.
    Burrows GE; Barto PB; Martin B
    Can J Vet Res; 1986 Apr; 50(2):193-9. PubMed ID: 3756673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.